OvaScience Inc (OVAS)’s Double Bottom Chart Pattern Points to Higher Stock Risks

November 7, 2017 - By Stephen Andrade

Investors sentiment is 0.66 in Q2 2017. Its the same as in 2017Q1. It is the same, as 22 investors sold OvaScience Inc shares while 19 reduced holdings. only 18 funds opened positions while 9 raised stakes. 20.08 million shares or 10.19% less from 22.36 million shares in 2017Q1 were reported.
Wells Fargo & Comm Mn has invested 0% in OvaScience Inc (NASDAQ:OVAS). Bank & Trust Of New York Mellon reported 31,628 shares. Bancorporation Of Montreal Can has invested 0% of its portfolio in OvaScience Inc (NASDAQ:OVAS). Morgan Stanley stated it has 104,282 shares or 0% of all its holdings. Jane Street Ltd reported 14,604 shares. Tortoise Inv Mgmt Ltd Liability holds 0% in OvaScience Inc (NASDAQ:OVAS) or 3,402 shares. 635,854 were reported by Franklin Inc. Northern Trust has invested 0% of its portfolio in OvaScience Inc (NASDAQ:OVAS). New York-based Oppenheimer & Co Inc has invested 0% in OvaScience Inc (NASDAQ:OVAS). Sabby Mngmt Limited Co has 509,300 shares. Third Security Ltd Llc reported 0.03% stake. Citadel Advisors Limited Liability reported 10,662 shares stake. Knott David M has 16,000 shares. Federated Invsts Incorporated Pa stated it has 2,262 shares or 0% of all its holdings. Millennium Limited Com invested in 0% or 417,807 shares.

The chart of OvaScience Inc (OVAS) shows a double bottom with $1.37 target or 8.00 % below today’s $1.49 share price. The 9 months chart pattern indicates high risk for the $53.29 million company. It was reported on Nov, 7 by Finviz.com. If the $1.37 price target is reached, the company will be worth $4.26M less. Double bottoms are rare but powerful chart patterns.

About 214,355 shares traded. OvaScience Inc (NASDAQ:OVAS) has declined 82.79% since November 7, 2016 and is downtrending. It has underperformed by 99.49% the S&P500.

OvaScience Inc (NASDAQ:OVAS) Ratings Coverage

Among 6 analysts covering OvaScience (NASDAQ:OVAS), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. OvaScience had 12 analyst reports since August 11, 2015 according to SRatingsIntel. Leerink Swann downgraded the stock to “Market Perform” rating in Monday, November 9 report. Oppenheimer downgraded the shares of OVAS in report on Monday, January 25 to “Perform” rating. Oppenheimer maintained the shares of OVAS in report on Wednesday, September 30 with “Outperform” rating. On Thursday, January 21 the stock rating was initiated by Credit Suisse with “Underperform”. On Tuesday, September 29 the stock rating was downgraded by JMP Securities to “Mkt Perform”. H.C. Wainwright maintained the stock with “Buy” rating in Friday, August 4 report. The stock of OvaScience Inc (NASDAQ:OVAS) has “Outperform” rating given on Wednesday, October 21 by Oppenheimer. The firm has “Buy” rating given on Monday, November 6 by H.C. Wainwright. The rating was maintained by Leerink Swann on Friday, August 14 with “Outperform”. The stock of OvaScience Inc (NASDAQ:OVAS) earned “Hold” rating by Oppenheimer on Thursday, June 22.

More news for OvaScience Inc (NASDAQ:OVAS) were recently published by: Businesswire.com, which released: “OvaScience to Host Third Quarter 2017 Financial Results Conference Call” on October 26, 2017. Businesswire.com‘s article titled: “OvaScience Reports Third Quarter 2017 Financial Results” and published on November 02, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.